Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Vladimir, Serebryany"'
Autor:
Cheng Liu, Sarah Stevens, Heleen Roose, Kha Le, Kristina Rekstyte-Matiene, Kusum Gupta, Sandra Chang, Vladimir Serebryany, Lillian Adame, Antitsa Stoycheva, Lawrence M Blatt, Leonid Beigelman, Sushmita Chanda, David B Smith, Julian A Symons, Andreas Jekle, Tongfei Wu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/c170486abb824f06906cb4f47c056214
Autor:
Cheng Liu, Sarah Stevens, Heleen Roose, Kha Le, Kristina Rekstyte-Matiene, Kusum Gupta, Sandra Chang, Vladimir Serebryany, Lillian Adame, Antitsa Stoycheva, Lawrence M Blatt, Leonid Beigelman, Sushmita Chanda, David B Smith, Julian A Symons, Andreas Jekle, Tongfei Wu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/875cd85b72334cbe84a2cbfc4b70946f
Autor:
Natalia Martynenko, Natalia Anisimova, Georgy Rybalchenko, Olga Rybalchenko, Vladimir Serebryany, Mark Zheleznyi, Maria Shinkareva, Artem Gorbenko, Diana Temralieva, Elena Lukyanova, Andrey Sannikov, Andrey Koltygin, Mikhail Kiselevskiy, Vladimir Yusupov, Sergey Dobatkin
Publikováno v:
Metals, Vol 13, Iss 8, p 1386 (2023)
A study of microstructure, phase composition, mechanical properties, corrosion processes, and biocompatibility in vitro of the Zn–1%Mg and Zn–1%Mg–0.1%Ca alloys in an annealed state and after rotary swaging (RS) is presented. Partially recrysta
Externí odkaz:
https://doaj.org/article/88bb53e0eff549d5991c80bfdcdee5ef
Autor:
Xinhe Yang, Yang Jin, Ruizhi Wu, Jiahao Wang, Dan Wang, Xiaochun Ma, Legan Hou, Vladimir Serebryany, Iya I. Tashlykova-Bushkevich, Sergey Ya. Betsofen
Publikováno v:
Metals, Vol 13, Iss 1, p 159 (2023)
Body-centered cubic (BCC) Mg–Li alloy can be effectively strengthened by with the addition of Al and Zn. However, adding excessive amounts result in reduced mechanical properties and damping capacity of the alloy during subsequent heat treatment an
Externí odkaz:
https://doaj.org/article/ec61ae3a41014c4e94a7edc8b87d1052
Autor:
Boris Straumal, Natalia Martynenko, Diana Temralieva, Vladimir Serebryany, Natalia Tabachkova, Igor Shchetinin, Natalia Anisimova, Mikhail Kiselevskiy, Alexandra Kolyanova, Georgy Raab, Regine Willumeit-Römer, Sergey Dobatkin, Yuri Estrin
Publikováno v:
Crystals, Vol 10, Iss 10, p 918 (2020)
The effect of equal channel angular pressing (ECAP) on the microstructure, texture, mechanical properties, and corrosion resistance of the alloys Mg-6.0%Ag and Mg-10.0%Gd was studied. It was shown that ECAP leads to grain refinement of the alloys dow
Externí odkaz:
https://doaj.org/article/87faffa572b24378b4f36591138ad7e6
Autor:
Antitsa Dimitrova Stoycheva, Leonid Beigelman, Tongqian Chen, Kenneth Shaw, Vivek K. Rajwanshi, Zhinan Jin, Andreas Jekle, Yujian Hu, Kusum Gupta, Caroline Williams, Amy Fung, Guangyi Wang, Vladimir Serebryany, Natalia B. Dyatkina, Xiangyang Wu, Marija Prhavc, Jerome Deval, David B. Smith, Wensheng Huang, Yuen Tam, Yongfei Huang
Publikováno v:
Journal of Medicinal Chemistry. 63:10380-10395
Chronic hepatitis C (CHC) is a major liver disease caused by the hepatitis C virus. The current standard of care for CHC can achieve cure rates above 95%; however, the drugs in current use are administered for a period of 8-16 weeks. A combination of
Autor:
Jerome Deval, Jin Hong, Guangyi Wang, Josh Taylor, Lucas K Smith, Amy Fung, Sarah K Stevens, Hong Liu, Zhinan Jin, Natalia Dyatkina, Marija Prhavc, Antitsa D Stoycheva, Vladimir Serebryany, Jyanwei Liu, David B Smith, Yuen Tam, Qingling Zhang, Martin L Moore, Rachel Fearns, Sushmita M Chanda, Lawrence M Blatt, Julian A Symons, Leo Beigelman
Publikováno v:
PLoS Pathogens, Vol 11, Iss 6, p e1004995 (2015)
Respiratory syncytial virus (RSV) causes severe lower respiratory tract infections, yet no vaccines or effective therapeutics are available. ALS-8176 is a first-in-class nucleoside analog prodrug effective in RSV-infected adult volunteers, and curren
Externí odkaz:
https://doaj.org/article/2d5adaa211d8415eabca3c2fc3171ff6
Autor:
Leonid Beigelman, Jerome Deval, Lawrence M. Blatt, Dorothée Bardiot, Laura Vangeel, Sandro Boland, Johan Neyts, Cheng Liu, Steven Dejonghe, Dinah Misner, Andreas Jekle, Pierre Raboisson, Sushmita Mukherjee Chanda, Vladimir Serebryany, Caroline S. Foo, Koen Vandyck, Arnaud Marchand, Suping Ren, Julian A. Symons, Patrick Chaltin, Kusum Gupta, Antitsa Dimitrova Stoycheva, Dirk Jochmans, Rana Abdelnabi
Publikováno v:
Biochemical and Biophysical Research Communications
There is an urgent need for antivirals targeting the SARS-CoV-2 virus to fight the current COVID-19 pandemic. The SARS-CoV-2 main protease (3CLpro) represents a promising target for antiviral therapy. The lack of selectivity for some of the reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f364b0af0bca75044f48bf96844cbe8
https://lirias.kuleuven.be/handle/123456789/673810
https://lirias.kuleuven.be/handle/123456789/673810
Autor:
Andreas Jekle, Julian A. Symons, Sushmita Mukherjee Chanda, Vladimir Serebryany, Leonid Beigelman, Cheng Liu, Rana Abdelnabi, Suping Ren, Steven Dejonghe, Sandro Boland, Johan Neyts, Dorothée Bardiot, Dinah Misner, Antitsa Dimitrova Stoycheva, Patrick Chaltin, Jerome Deval, Pierre Raboisson, Kusum Gupta, Koen Vandyck, Dirk Jochmans, Caroline S. Foo, Arnaud Marchand, Lawrence M. Blatt, Laura Vangeel
There is an urgent need for antivirals targeting the SARS-CoV-2 virus to fight the current COVID-19 pandemic. The SARS-CoV-2 main protease (3CLpro) represents a promising target for antiviral therapy. The lack of selectivity for some of the reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b7502a8f400fdb028d390f18fc0e96d
https://doi.org/10.1101/2021.02.14.431129
https://doi.org/10.1101/2021.02.14.431129
Autor:
Guangyi, Wang, Natalia, Dyatkina, Marija, Prhavc, Caroline, Williams, Vladimir, Serebryany, Yujian, Hu, Yongfei, Huang, Xiangyang, Wu, Tongqian, Chen, Wensheng, Huang, Vivek K, Rajwanshi, Jerome, Deval, Amy, Fung, Zhinan, Jin, Antitsa, Stoycheva, Kenneth, Shaw, Kusum, Gupta, Yuen, Tam, Andreas, Jekle, David B, Smith, Leonid, Beigelman
Publikováno v:
Journal of medicinal chemistry. 63(18)
Chronic hepatitis C (CHC) is a major liver disease caused by the hepatitis C virus. The current standard of care for CHC can achieve cure rates above 95%; however, the drugs in current use are administered for a period of 8-16 weeks. A combination of